Clinical Study Results
Where can I learn more about this study?
You can find more information about this study on the websites listed below. If a full
report of the study results is available, it can also be found here.
• www.clinicaltrials.gov. Once you are on the website, type “NCT03091192”
into the search box, and click “Search”.
• www.clinicaltrialsregister.eu. Once you are on the website, click “Home
and Search”, then type “2016-004108-73” in the search box, and click
“Search”.
• www.AstraZenecaClinicalTrials.com. Once you are on the website, type
“D5082C00003” into the search box, and click “Find a Study”.
Full Trial Title: A Phase III, Open Label, Randomised, Controlled, Multi-Centre
Study to Assess the Efficacy and Safety of Savolitinib versus Sunitinib in Patients
with MET-Driven, Unresectable and Locally Advanced, or Metastatic Papillary
Renal Cell Carcinoma (PRCC)
National Clinical Trials Number: NCT03091192
AstraZeneca Protocol Number: D5082C00003
EudraCT Number: 2016-004108-73
AstraZeneca, sponsored this study and has its headquarters in Cambridge, UK.
The phone number for the AstraZeneca Information Center is +1-877-240-9479.
Thank you!
Clinical study participants belong to a large community of people who take part in
clinical research around the world. They help researchers answer important health
questions and find medical treatments for patients.
The Center for Information & Study on Clinical Research
Participation (CISCRP) is a non-profit organization focused
on educating and informing the public about clinical research
participation. CISCRP is not involved in recruiting participants for
clinical studies, nor is it involved in conducting clinical studies.
CISCRP
One Liberty Square, Suite 1100 • Boston, MA 02109
1-877-MED-HERO • www.ciscrp.org
Version 1.0 2020_04_02 12